• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 30, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

Bioengineer by Bioengineer
July 30, 2026
in Biology
Reading Time: 1 min read
0
Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

blank

McCallin, S., Classen, A.Y., Lieberknecht-Jouy, S.C. et al. Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series.
Nat Microbiol 11, 2112–2118 (2026). https://doi.org/10.1038/s41564-026-02409-0

August 2026

Share12Tweet7Share2ShareShareShare1

Related Posts

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

July 30, 2026
Essential genetic mutations impair DNA damage repair and modulate tumor immune microenvironment in ccRCC

Essential genetic mutations impair DNA damage repair and modulate tumor immune microenvironment in ccRCC

July 30, 2026

Microbiota-derived 10-hydroxystearic acid activates PPARα to restore gut epithelial barrier integrity and enhance anti-retroviral therapy

July 30, 2026

Amazonian ‘zombie’ fungus harbors a hidden stage inside forest mosses, new study reveals

July 30, 2026

POPULAR NEWS

  • Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

    29 shares
    Share 12 Tweet 7
  • Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

    29 shares
    Share 12 Tweet 7
  • Representations of the intrinsic value of information in mouse orbitofrontal cortex

    29 shares
    Share 12 Tweet 7
  • Pilot study to validate endothelium collection from pulmonary artery balloon catheter in children

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cemiplimab and fianlimab with neoadjuvant chemotherapy in early-stage high-risk -negative breast cancer

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

Representations of the intrinsic value of information in mouse orbitofrontal cortex

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.